Henu Kumar Verma (Henu Verma)

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 17

Top Venues

Current treatment options in oncology

Journal of clinical medicine

Diseases (Basel, Switzerland)

Oxidative medicine and cellular longevity

Institute Experimental Endocrinology and Oncology (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Institute Experimental Endocrinology and Oncology

Italy

PHD :: Molecular Biology

Publications

Chahat Suri, Meenakshi Sinha, Tarun Sahu, Lakkakula Suhasini Sahithi, Henu Kumar Verma
Revolutionizing Gastrointestinal Disorder Management: Cutting-Edge Advances and Future Prospects. Journal of clinical medicine 13 (13) (2024)
Vincenzo Costanzo, Yashwant Kumar Ratre, Emanuela Andretta, Rakesh Acharya, L V K S Bhaskar, Henu Kumar Verma
A Comprehensive Review of Cancer Drug-Induced Cardiotoxicity in Blood Cancer Patients: Current Perspectives and Therapeutic Strategies. Current treatment options in oncology 25 (4) (2024)
Chahat Suri, Meenakshi Sinha, Tarun Sahu, Lakkakula Suhasini Sahithi, Henu Kumar Verma
Revolutionizing Gastrointestinal Disorder Management: Cutting-Edge Advances and Future Prospects. Journal of clinical medicine 13 (13) (2024)
Pratik Mohanty, Meenakshi Sinha, Rakesh Acharya, Bhaskar V K S Lakkakula, Henu Kumar Verma
Unravelling the Triad of Lung Cancer, Drug Resistance, and Metabolic Pathways. Diseases (Basel, Switzerland) 12 (5) (2024)
Pratik Mohanty, Meenakshi Sinha, Rakesh Acharya, Bhaskar V K S Lakkakula, Henu Kumar Verma
Unravelling the Triad of Lung Cancer, Drug Resistance, and Metabolic Pathways. Diseases (Basel, Switzerland) 12 (5) (2024)
Vincenzo Costanzo, Yashwant Kumar Ratre, Emanuela Andretta, Rakesh Acharya, L V K S Bhaskar, Henu Kumar Verma
A Comprehensive Review of Cancer Drug-Induced Cardiotoxicity in Blood Cancer Patients: Current Perspectives and Therapeutic Strategies. Current treatment options in oncology 25 (4) (2024)
Vincenzo Costanzo, Yashwant Kumar Ratre, Emanuela Andretta, Rakesh Acharya, L V K S Bhaskar, Henu Kumar Verma
A Comprehensive Review of Cancer Drug-Induced Cardiotoxicity in Blood Cancer Patients: Current Perspectives and Therapeutic Strategies. Current treatment options in oncology (2024)
Vincenzo Costanzo, Yashwant Kumar Ratre, Emanuela Andretta, Rakesh Acharya, L V K S Bhaskar, Henu Kumar Verma
A Comprehensive Review of Cancer Drug-Induced Cardiotoxicity in Blood Cancer Patients: Current Perspectives and Therapeutic Strategies. Current treatment options in oncology 25 (4) (2024)
Rakesh Acharya, Ananya Mahapatra, Henu Kumar Verma, Bhaskar V K S Lakkakula
Unveiling Therapeutic Targets for Esophageal Cancer: A Comprehensive Review. Current oncology (Toronto, Ont.) 30 (11) (2023)
Udit Narayan Padhi, Madhubala Mulkalwar, Lakkakula Saikrishna, Henu Kumar Verma, Bhaskar V K S Lakkakula
NOS3 gene intron 4 a/b polymorphism is associated with ESRD in autosomal dominant polycystic kidney disease patients. Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia 44 (2) (2022)
Poojarani Panda, Henu Kumar Verma, Saikrishna Lakkakula, Neha Merchant, Fairrul Kadir, Shamsur Rahman, Mohammad Saffree Jeffree, Bhaskar V K S Lakkakula, Pasupuleti Visweswara Rao
Biomarkers of Oxidative Stress Tethered to Cardiovascular Diseases. Oxidative medicine and cellular longevity 2022 (2022)
Tarun Sahu, Babita Pande, Meenakshi Sinha, Ramanjan Sinha, Henu Kumar Verma
Neurocognitive Changes in Sickle Cell Disease: A Comprehensive Review. Annals of neurosciences 29 (4) (2022)
Henu Kumar Verma, Yashwant Kumar Ratre, L V K S Bhaskar, Raffaella Colombatti
Erythrocyte microRNAs: a tiny magic bullet with great potential for sickle cell disease therapy. Annals of hematology 100 (3) (2021)
Manas R Purohit, Lakkakula Saikrishna, Henu Kumar Verma, L V K S Bhaskar, Syed A Hussain
Association Between MTHFD1 1958G > A Variant and non-Syndromic Cleft lip and Palate: An Updated Meta-Analysis. The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association 59 (11) (2021)
Yashwant Kumar Ratre, Namrata Kahar, L V K S Bhaskar, Antaripa Bhattacharya, Henu Kumar Verma
Molecular mechanism, diagnosis, and potential treatment for novel coronavirus (COVID-19): a current literature review and perspective. 3 Biotech 11 (2) (2021)
Yashwant Kumar Ratre, Naveen Kumar Vishvakarma, L V K S Bhaskar, Henu Kumar Verma
Dynamic Propagation and Impact of Pandemic Influenza A (2009 H1N1) in Children: A Detailed Review. Current microbiology 77 (12) (2020)
Henu Kumar Verma, Batoul Farran, Lakkakula V K S Bhaskar
Convalescent plasma transfusion a promising therapy for coronavirus diseases 2019 (COVID-19): current updates. Antibody therapeutics 3 (2) (2020)

Henu Kumar Verma.css-eqlu8i{font-size:small;padding-left:4px;} (Henu Verma)

Publication Activity (10 Years)

Top Topics

Top Venues

Henu Kumar Verma (Henu Verma)